Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock

Annals of Surgery

Volumn 245, Issue 4, 2007, Pages 635-641

  Bulger, Eileen M ^a   Cuschieri, Joseph ^a   Warner, Keir ^a   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; DEXTRAN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLUID RESUSCITATION; FLUORESCENCE ACTIVATED CELL SORTING; HEMORRHAGIC SHOCK; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL; RESPIRATORY BURST; STIMULATION;

ADULT; ANTIGENS, CD11B; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHIL ACTIVATION; RESUSCITATION; SALINE SOLUTION, HYPERTONIC; SHOCK, HEMORRHAGIC;

EID: 34147179914     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000251367.44890.ae     Document Type: Article

References (40)

1. Holcroft JW, Vassar MJ, Perry CA, et al. Use of a 7.5% NaCl/6% Dextran 70 solution in the resuscitation of injured patients in the emergency room. Prog Clin Biol Res. 1989;299:331-338.
2. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension: the U.S.A. Multicenter Trial. Ann Surg. 1991;213:482-491.
3. Vassar MJ, Perry CA, Gannaway WL, et al. 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch Surg. 1991;126:1065-1072.
4. Younes RN, Aun F, Accioly CQ, et al. Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room. Surgery. 1992;111:380-385.
5. Vassar MJ, Fischer RP, O'Brien PE, et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride: the effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg. 1993;128:1003-1011; discussion 1011-1003.
6. Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA. 2004;291:1350-1357.
7. Wade C, Grady J, Kramer G. Efficacy of hypertonic saline dextran (HSD) in patients with traumatic hypotension: meta-analysis of individual patient data. Acta Anaesthesiol Scand Suppl. 1997;110:77-79.
8. Wade CE, Grady JJ, Kramer GC. Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma. J Trauma. 2004;54(suppl 5):144-148.
9. Wade CE, Grady JJ, Kramer GC, et al. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma. 1997;42(suppl 5):61-65.
10. Wade CE, Kramer GC, Grady JJ, et al. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery. 1997;122:609-616.
11. Kolsen-Petersen JA. Immune effect of hypertonic saline: fact or fiction? Acta Anaesthesiol Scand. 2004;48:667-678.
12. Junger WG, Coimbra R, Liu FC, et al. Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients? Shock. 1997;8:235-241.
13. Rizoli SB. Immunomodulatory effects of hypertonic saline resuscitation of traumatic hemorrhagic shock: a pilot randomized controlled trial. Circulation. 2003;108:1029.
14. Rizoli SB, Rhind SG, Shek PN, et al. The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg. 2006;243:47-57.
15. Smith GJ, Kramer GC, Perron P, et al. A comparison of several hypertonic solutions for resuscitation of bled sheep. J Surg Res. 1985;39:517-528.
16. Wade CE, Hannon JP, Bossone CA, et al. Superiority of hypertonic saline/dextran over hypertonic saline during the first 30 min of resuscitation following hemorrhagic hypotension in conscious swine. Resuscitation. 1990;20:49-56.
17. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638-1652.
18. Pick E. Microassays for superoxide and hydrogen peroxide production and nitro-blue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol. 1986;132:407-421.
19. Pick E, Charon J, Mizel D. A rapid densitometric microassay for nitro-blue tetrazolium reduction and application of the microassay to macrophages. J Reticuloendothel Soc. 1981;30:581-593.
20. Maier RV. Pathogenesis of multiple organ dysfunction syndrome - endotoxin, inflammatory cells, and their mediators: cytokines and reactive oxygen species. Surg Infect (Larchmt). 2000;1:197-205.
21. Rizoli SB, Rotstein OD, Parodo J, et al. Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling. Am J Physiol Cell Physiol. 2000;279:C619-C633.
22. Junger WG, Hoyt DB, Davis RE, et al. Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest. 1998;101:2768-2779.
23. Angle N, Hoyt DB, Cabello-Passini R, et al. Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression. J Trauma. 1998;45:7-12; discussion 12-13.
24. Rizoli SB, Kapus A, Parodo J, et al. Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression. J Surg Res. 1999;83:130-135.
25. Rizoli SB, Kapus A, Parodo J, et al. Hypertonicity prevents lipopolysaccharide-stimulated CD11b/CD18 expression in human neutrophils in vitro: role for p38 inhibition. J Trauma. 1999;46:794-798; discussion 798-799.
26. Thiel M, Buessecker F, Eberhardt K, et al. Effects of hypertonic saline on expression of human polymorphonuclear leukocyte adhesion molecules. J Leukoc Biol. 2001;70:261-273.
27. Rizoli SB, Kapus A, Fan J, et al. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol. 1998;161:6288-6296.
28. Angle N, Hoyt DB, Coimbra R, et al. Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock. 1998;9:164-170.
29. Cuschieri J, Gourlay D, Garcia I, et al. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol. 2002;168:1389-1396.
30. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71-82.
31. Ziegler-Heitbrock HW. Definition of human blood monocytes. J Leukoc Biol. 2000;67:603-606.
32. Frankenberger M, Sternsdorf T, Pechumer H, et al. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood. 1996;87:373-377.
33. Skrzeczynska J, Kobylarz K, Hartwich Z, et al. CD14+CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scand J Immunol. 2002;55:629-638.
34. Kampalath B, Cleveland RP, Chang CC, et al. Monocytes with altered phenotypes in posttrauma patients. Arch Pathol Lab Med. 2003;127:1580-1585.
35. Faist E, Mewes A, Strasser T, et al. Alteration of monocyte function following major injury. Arch Surg. 1988;123:287-292.
36. Miller-Graziano CL, Szabo G, Kodys K, et al. Aberrations in posttrauma monocyte (MO) subpopulation: role in septic shock syndrome. J Trauma. 1990;30(suppl 12):86-96.
37. Shahbazian LM, Jeevanandam M, Petersen SR. Release of proinflammatory cytokines by mitogen-stimulated peripheral blood mononuclear cells from critically ill multiple-trauma victims. Metabolism. 1999;48:1397-1401.
38. Murao Y, Loomis W, Wolf P, et al. Effect of dose of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock. Shock. 2003;20:29-34.
39. Stapley SA, Clasper JC, Horrocks CL, et al. The effects of repeated dosing with 7.5% sodium chloride/6% dextran following uncontrolled intra-abdominal hemorrhage. Shock. 2002;17:146-150.
40. Riddez L, Drobin D, Sjostrand F, et al. Lower dose of hypertonic saline dextran reduces the risk of lethal rebleeding in uncontrolled hemorrhage. Shock. 2002;17:377-382.